69 related articles for article (PubMed ID: 38494294)
21. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
22. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
23. Imaging Review of Paraneoplastic Neurologic Syndromes.
Madhavan AA; Carr CM; Morris PP; Flanagan EP; Kotsenas AL; Hunt CH; Eckel LJ; Lindell EP; Diehn FE
AJNR Am J Neuroradiol; 2020 Dec; 41(12):2176-2187. PubMed ID: 33093137
[TBL] [Abstract][Full Text] [Related]
24. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic neurological syndromes.
Graus F; Dalmau J
Curr Opin Neurol; 2012 Dec; 25(6):795-801. PubMed ID: 23041955
[TBL] [Abstract][Full Text] [Related]
26. Paraneoplastic antibodies targeting intracellular antigens.
Linnoila JJ
Handb Clin Neurol; 2024; 200():335-346. PubMed ID: 38494288
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
28. [Paraneoplastic neurological syndromes and autoimmune encephalitis].
Stich O; Rauer S
Nervenarzt; 2014 Apr; 85(4):485-98; quiz 499-501. PubMed ID: 24668402
[TBL] [Abstract][Full Text] [Related]
29. [Pathology of paraneoplastic syndromes of the central and peripheral nervous systems and muscle ].
Ferrer I
Rev Neurol; 2000 Dec 16-31; 31(12):1228-36. PubMed ID: 11211860
[TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic cerebellar and brainstem disorders.
Abbatemarco JR; Vedeler CA; Greenlee JE
Handb Clin Neurol; 2024; 200():173-191. PubMed ID: 38494276
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic neurological syndromes.
Honnorat J; Antoine JC
Orphanet J Rare Dis; 2007 May; 2():22. PubMed ID: 17480225
[TBL] [Abstract][Full Text] [Related]
32. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
[TBL] [Abstract][Full Text] [Related]
33. Update on neurological paraneoplastic syndromes.
Höftberger R; Rosenfeld MR; Dalmau J
Curr Opin Oncol; 2015 Nov; 27(6):489-95. PubMed ID: 26335665
[TBL] [Abstract][Full Text] [Related]
34. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
Dalmau J; Porta-Etessam J
Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
[TBL] [Abstract][Full Text] [Related]
35. Paraneoplastic disorders of the central and peripheral nervous systems.
Didelot A; Honnorat J
Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
[TBL] [Abstract][Full Text] [Related]
36. Clinical approach to diagnosis of paraneoplastic neurologic syndromes.
Graus F
Handb Clin Neurol; 2024; 200():79-96. PubMed ID: 38494298
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic neuropathies.
Graus F; Dalmau J
Curr Opin Neurol; 2013 Oct; 26(5):489-95. PubMed ID: 23892629
[TBL] [Abstract][Full Text] [Related]
38. POEMS syndrome: update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2015 Oct; 90(10):951-62. PubMed ID: 26331353
[TBL] [Abstract][Full Text] [Related]
39. [Crow-Fukase (POEMS) syndrome].
Kuwabara S
Brain Nerve; 2010 Apr; 62(4):395-400. PubMed ID: 20420180
[TBL] [Abstract][Full Text] [Related]
40. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
Kamezaki K; Nagafuji K
Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
